It was found that the 5"-hydroxy group of ribostamycin was preferentially phosphorylated by a cell-free extract from Pseudomonas aeruginosa GN 573, a clinical isolate.
Previous reports have revealed that various resistant strains inactivate certain aminoglycosides by phosphorylation at the 3'-or 3"-hydroxy group of aminoglucose moiety in each case. Thus, streptomycin and dihydrostreptomycin were phosphorylated at the 3"-hydroxy group of N-methyl-L-glucosamine moiety (1, 5) . Kanamycin and paromamine were phosphorylated at the 3'-hydroxy group of 6-aminoglucose or glucosamine moiety (3) . Similarly, butirosin A, ribostamycin, and neamine were also inactivated by phosphorylation at the 3'-hydroxy group of the 2,6-diaminoglucose moiety (7) .
However, we have found recently that the 5"-hydroxy group of ribostamycin was preferentially phosphorylated by a cell-free extract from Pseudomonas aeruginosa GN 573 isolated from a clinical specimen in spite of the presence of the 3'-hydroxy group of the 2,6-diaminoglucose moiety.
The early-log-phase cells of P. aeruginosa GN 573 were disrupted for 5 min by a sonic oscillator, and the supernatant fluid, after 30,000 x g centrifugation, was prepared as a crude extract. Ribostamycin was inactivated at 37 C in a reaction mixture containing 3.3 mmol of ribostamycin, 1,280 mg of crude extract protein, 15 mmol of adenosine-5'-triphosphate, 37.5 mmol of potassium phosphate buffer (pH 7.0), 7.5 mmol of 2-mercaptoethanol, 15 mmol of magnesium acetate, and 150 mmol of potassium chloride. The total volume was made up to 750 ml with distilled water. After 20 h of incubation, the reaction mixture was heated for 5 min at 80 C to stop the reaction and was filtered. The antimicrobial activity of the filtrate was determined by a paper disk method by using Bacillus subtilis PCI 219.
The filtrate was poured onto a column of Amberlite IRC 50 (NH,+ form, 500 ml). After washing the column with 3 liters of distilled water, the inactivated ribostamycin was eluted with 0.5 N aqueous ammonia. The eluate, which gave a positive reaction by peptide-bond detection reagent (Seikagaku Kogyo Co., Ltd., Tokyo, Japan), was collected and condensed to approximately 1 liter under reduced pressure. After the condensed solution was subjected to column chromatography over Amberlite CG 50 (NH4+ form, 275 ml), 3 liters of distilled water and 1 liter of 0.5 N aqueous ammonia were passed through the column, and the fraction containing the inactivated ribostamycin was condensed to 50 ml. A 15-ml sample of the fraction was applied on a column of CM Sephadex C 25 (NH,+ form, 550 ml), and the column was washed with 1.2 liters of distilled water and eluted with a linear gradient formed from 1 liter of distilled water and 1 liter of 0.03 N aqueous ammonia. A thin-layer chromatography of the eluates is shown in Fig. 1 . Fractions I and II were concentrated and lyophilized, yielding 18 mg and 1,620 mg, respectively. The main product of the inactivated ribostamycin, fraction II and the minor product, fraction I showed no antimicrobial activities at 1 mg/ml by the paper disk method. Hydrolysis of the inactivated products, fractions I and II by alkaline phosphatase (Escherichia coli, Sigma), yielded ribostamycin (Fig. 2) .
The characteristics of fraction I were as follows. Analysis: calculated for C 17H3,N40 3P. Fractions I and II were refluxed with 0.4 N hydrogen chloride in methanol for 3 h, and methanolysis products were obtained by Amberlite CG 50 (NH,+ form) column chromatography. The product obtained from Fraction II was found to correspond to neamine on thin-layer chromatography, whereas that of fraction I corresponded to neamine-3'-phosphate which was derived from neamine and adenosine-5'-triphosphate by the crude extract of E. coli JR66/W677. The amount of periodate consumed was determined by the titration method reported by Fleury and Lange (2) Thin-layer chromatography and bioautography of fractions I and II and the products treated with alkaline phosphatase. Thin-layer chromatography was carried out by the same procedure described in Fig. 1 
